A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
Zhang H, Yun S, Batuwangala TD, Steward M, Holmes SD, Pan L, Tighiouart M, Shin HJ, Koenig L, Park W, Rycroft D, Nannapaneni S, Wang Y, Chen ZG, Shin DM.
Zhang H, et al. Among authors: wang y.
Int J Cancer. 2012 Aug 15;131(4):956-69. doi: 10.1002/ijc.26427. Epub 2011 Nov 19.
Int J Cancer. 2012.
PMID: 21918971
Free article.